Newsroom
Neglected Tropical Diseases: World Health Assembly endorses bold new road map targets for 2030
12 November, 2020 | World Health Organization
12 November 2020 — Today, delegates attending the virtual session of the Seventy-third World Health Assembly overwhelmingly endorsed the new road map for neglected tropical diseases (NTDs) for 2021−2030. Ending the neglect to attain the Sustainable Development Goals: a road … More Neglected Tropical Diseases: World Health Assembly endorses bold new road map targets for 2030
SDR-PEP Webinar Series: The Role of Persons Affected in SDR-PEP Implementation
6 November, 2020 | Global Partnership for Zero Leprosy
The Global Partnership for Zero Leprosy, along with WHO Global Leprosy Programme, launched an SDR-PEP-focused webinar series. The first webinar in this series explored the process of starting SDR-PEP implementation for National Leprosy Programmes. The second webinar will address the … More SDR-PEP Webinar Series: The Role of Persons Affected in SDR-PEP Implementation
GPZL Presents Prioritisation of the Zero Leprosy Research Agenda
4 November, 2020 | Global Partnership for Zero Leprosy
The Global Partnership for Zero Leprosy (GPZL) presented the prioritised Zero Leprosy Research Agenda at the WHO Global Consultation on Global Leprosy Strategy 2021 – 2030 last week. In 2018, the Research Agenda working group’s eight different sub-groups conducted a … More GPZL Presents Prioritisation of the Zero Leprosy Research Agenda
Sasakawa Health Foundation Announces Grant Recipients: Organizations of Persons Affected by Leprosy During COVID-19
4 November, 2020 | Sasakawa Health Foundation
TOKYO, Oct. 29, 2020 — Sasakawa Leprosy (Hansen’s Disease) Initiative will launch a US$340,000 grant program on November 1 to support communities of persons affected by leprosy around the world that have been hard hit by the effects of the … More Sasakawa Health Foundation Announces Grant Recipients: Organizations of Persons Affected by Leprosy During COVID-19
Contact tracing with prophylactic treatment could near-eliminate leprosy in a single generation, new research suggests
2 November, 2020 | Novartis International AG
Results from the Novartis Foundation-initiated Leprosy Post-Exposure Prophylaxis (LPEP) program covered more than 150,000 people across seven countries Post-exposure prophylaxis with a single dose of the antibiotic rifampicin is safe, can be integrated into different leprosy control programs, and is … More Contact tracing with prophylactic treatment could near-eliminate leprosy in a single generation, new research suggests
Grant Program for Organizations of Persons Affected by Leprosy/Hansen’s Disease During the COVID-19 Pandemic
24 September, 2020 | Sasakawa Health Foundation
Sasakawa Health Foundation with support from The Nippon Foundation is implementing a grant program for organizations of persons affected by leprosy/Hansen’s disease to support people who have been severely impacted by the unprecedented crisis caused by the spread of the … More Grant Program for Organizations of Persons Affected by Leprosy/Hansen’s Disease During the COVID-19 Pandemic
Bill Gallo Joins GPZL as Secretariat Director
15 September, 2020 | Global Partnership for Zero Leprosy
Bill Gallo joins the Global Partnership for Zero Leprosy (GPZL) this month as Secretariat Director. He brings with him a wealth of knowledge in global health and diverse experiences in policy and programme management. He is excited to take on … More Bill Gallo Joins GPZL as Secretariat Director
The COVID-19 Crisis and Persons Affected by Leprosy: Questionnaire Results
9 September, 2020 | Global Partnership for Zero Leprosy
The economic, social, and health impacts of the COVID-19 pandemic have led to a significant increase in the need for humanitarian aid and social protection measures. Persons affected by leprosy have been especially impacted by the worst consequences of the pandemic, due to preexisting vulnerabilities and economic precarity.
Governments, NGOs, civil society organizations, and organizations of persons affected by leprosy have enacted policies and programmes intended to support persons affected during this crisis, although there are still gaps. To support the effectiveness of these interventions, and to help raise awareness of resources available to persons affected, the Global Partnership for Zero Leprosy’s COVID-19 Emergency Advocacy Working Group and UN Special Rapporteur on the elimination of discrimination against persons affected by leprosy and their family members Alice Cruz, gathered data on available programmes and resources. The following information was gathered through an online questionnaire from 100+ persons affected and partners, representing 24 countries.
ILEP Technical Commission and Advisory Panels accepting nominations
28 August, 2020 | Global Partnership for Zero Leprosy
The ILEP Technical Commission and the ILEP Advisory Panel both come up for re-appointment in October. The two groups work closely with one another to coordinate guidance at ILEP Federation. The ILEP Technical Commission includes experts covering a range of … More ILEP Technical Commission and Advisory Panels accepting nominations
Open letter to Laois City Councilor Willie Aird, organized by a global network of persons affected by leprosy
14 August, 2020 | Global Partnership for Zero Leprosy
An open letter to Laois City Councilor Willie Aird, written by a global network of persons affected by leprosy, in response to his recent public comments.
GPZL’s COVID-19 Working Groups: August 2020 Update
11 August, 2020 | Global Partnership for Zero Leprosy
The COVID-19 pandemic has strongly impacted leprosy control and prevention, and in response, GPZL has established three working groups to address the leprosy community’s key challenges during the global health crisis, and spearhead emergency response. This article is an update on their progress.
Novartis Kalwe Site Associates Live On-Site during COVID-19 Lockdown to Maintain Multi-Drug Therapy Supply Chain for WHO Donation Program
6 August, 2020 | Global Partnership for Zero Leprosy
The COVID-19 pandemic has halted many leprosy control and prevention activities globally, putting vulnerable communities further at risk. The Novartis Technical Operations (NTO) Sandoz Kalwe site, located north of Mumbai on India’s west coast, faced new challenges beginning earlier this … More Novartis Kalwe Site Associates Live On-Site during COVID-19 Lockdown to Maintain Multi-Drug Therapy Supply Chain for WHO Donation Program
UN Special Rapporteur Alice Cruz’s mandate extended by Human Rights Council
30 July, 2020 | Global Partnership for Zero Leprosy
The UN Human Rights Council has extended the mandate of Alice Cruz, UN Special Rapporteur on the elimination of discrimination against persons affected by leprosy and their family members. Alice has advocated for persons affected by leprosy and their families … More UN Special Rapporteur Alice Cruz’s mandate extended by Human Rights Council
Search for New Project Manager
20 July, 2020 | Global Partnership for Zero Leprosy
The Global Partnership for Zero Leprosy (GPZL) team is growing. We are looking for a new Associate Director of Programs to join the Secretariat. This person will develop, coordinate, and monitor GPZL’s national partnerships. Activities may include an initial assessment … More Search for New Project Manager
GPZL’s 2020 Country Partners
14 July, 2020 | Global Partnership for Zero Leprosy
The Global Partnership for Zero Leprosy (GPZL) is working toward a world without leprosy through a country-by-country strategy. We bring together partners in-country and international stakeholders to work on country-led customized strategies that address local needs and priorities to end … More GPZL’s 2020 Country Partners
SDR-PEP Webinar Series: Post Exposure Prophylaxis in Leprosy Programs
14 July, 2020 | Global Partnership for Zero Leprosy
The Global Partnership for Zero Leprosy, along with WHO GLP, recently launched a new SDR-PEP focused webinar series. The first webinar in this series took place on 18 June 2020 and explored the process of starting SDR-PEP implementation for National Leprosy Programmes.
Thank you to Courtenay Dusenbury, GPZL Secretariat Director
13 July, 2020 | Global Partnership for Zero Leprosy
Courtenay Dusenbury joined the Global Partnership for Zero Leprosy (GPZL) in January 2018, just as it was preparing to launch. Courtenay brought with her a background in global health partnerships and prior directorial experience as Founding Director of the International … More Thank you to Courtenay Dusenbury, GPZL Secretariat Director
UN Special Rapporteur on the Elimination of Discrimination Against Persons Affected by Leprosy and Their Family Members presents thematic report to Human Rights Council
7 July, 2020 | Global Partnership for Zero Leprosy
Special Rapporteur on the elimination of discrimination against persons affected by leprosy and their family members, Alice Cruz, presented her thematic report to the United Nations Human Rights Council on 6 July.
GPZL’s COVID-19 Working Groups: June 2020 Update
16 June, 2020 | Global Partnership for Zero Leprosy
The COVID-19 pandemic has strongly impacted leprosy control and prevention, and in response, GPZL has established three working groups to address the leprosy community’s key challenges during the global health crisis, and spearhead emergency response. This article is an update on their progress.
Thank you to Dr. Christine Fenenga: A foundational contributor to GPZL
16 June, 2020 | Global Partnership for Zero Leprosy
Dr. Christine Fenenga, MPH, PhD, has has played an important role in the foundation of the Global Partnership, shaping GPZL’s Operational Excellence work since joining the Secretariat in 2018. Her contributions have been essential to the growth and success of this partnership and will be remembered worldwide.